However, the recommendation also stresses close monitoring, gradual reductions in insulin doses, maintaining adequate carbohydrate intake, ketone testing, sick-day rules and careful dose titration [4]
Specializes in platelet-rich plasma therapy to accelerate healing and recovery
Our proposed method does not require an antibody and is more stable in time, biocompatible and uses a simpler and straightforward system that can be further developed into a visual/colorimetric sensor
short-term refrigeration at around 39F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines
Innovent is developing a proprietary GLP-1/glucagon dual-receptor agonist called mazdutide, which was found to significantly outperform semaglutide in a head-to-head Phase III (DREAMS-3) trial last year, achieving superior blood sugar control and greater weight loss in patients with type 2 diabetes and obesity
Alongside these treatments, the prevention of obesity through lifestyle modifications remains crucial
